Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Nervous System Diseases 1Epilepsy 1Brain Neoplasms 1

Interventions

Proton Therapy 2pegvisomant 1lutetium Lu 177 dotatate 1entinostat 1Temozolomide 1Surveys and Questionnaires 1Rosiglitazone 1Radiation Dose Hypofractionation 1Protons 1Prednisone 1Photochemotherapy 1Octreotide 1Neuropsychological Tests 1Microarray Analysis 1Hydrocortisone 1Dihematoporphyrin Ether 1Dexamethasone 1DNA Methylation 1Clinical Laboratory Techniques 1Calcium Dobesilate 1Cabergoline 1Blood Specimen Collection 1Aminolevulinic Acid 190Y-octreotide, DOTA-Tyr(3)- 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Clinical Laboratory Techniques × CNS × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡